Literature DB >> 1941151

Neutron-activated holmium-166-poly (L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors.

R J Mumper1, U Y Ryo, M Jay.   

Abstract

Biodegradable Poly(L-lactic acid) microspheres containing neutron-activable 165Ho were designed for internal radiation therapy of hepatic tumors. Spheres composed of Poly(L-lactic acid) (PLA) were prepared with excellent reproducibility containing up to 36% of a holmium complex. The prepared spheres were irradiated in a high neutron flux converting 165Ho to 166Ho (Emax = 1.84 MeV, half-life = 26.9 hr). Thus, these microspheres can be prepared under conditions that do not require the handling of a hazardous radionuclide, and then irradiated just prior to administration. In vitro studies in plasma (n = 6) revealed 97.3% (+/- 1.9) retention of 166Ho in the microspheres after 240 hr. PLA spheres administered via the portal vein in rabbits (n = 6) show 94.5% (+/- 3.4) retention of the original 166Ho activity in the liver after 6 days.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941151

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.

Authors:  D W Cagle; S J Kennel; S Mirzadeh; J M Alford; L J Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Metal-containing and related polymers for biomedical applications.

Authors:  Yi Yan; Jiuyang Zhang; Lixia Ren; Chuanbing Tang
Journal:  Chem Soc Rev       Date:  2016-02-24       Impact factor: 54.564

Review 3.  Theragnostic potentials of core/shell mesoporous silica nanostructures.

Authors:  Aswathy Ravindran Girija; Sivakumar Balasubramanian
Journal:  Nanotheranostics       Date:  2019-01-01

Review 4.  Treatment of hepatocellular carcinoma by means of radiopharmaceuticals.

Authors:  Bieke Lambert; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08       Impact factor: 9.236

Review 5.  Holmium-166 Radioembolization: Current Status and Future Prospective.

Authors:  Martina Stella; Arthur J A T Braat; Rob van Rooij; Hugo W A M de Jong; Marnix G E H Lam
Journal:  Cardiovasc Intervent Radiol       Date:  2022-06-21       Impact factor: 2.740

6.  A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.

Authors:  Byoung Chul Cho; Eun Hee Kim; Hye Jin Choi; Joo Hang Kim; Jae Kyung Roh; Hyun Cheol Chung; Joong Bae Ahn; Jong Doo Lee; Jong Tae Lee; Nae Choon Yoo; Joo Hyuk Sohn
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

7.  In-Situ Formation of Holmium Oxide in Pores of Mesoporous Carbon Nanoparticles as Substrates for Neutron-Activatable Radiotherapeutics.

Authors:  Junghyun Kim; Zhi-Xiang Luo; Yue Wu; Xiuling Lu; Michael Jay
Journal:  Carbon N Y       Date:  2017-02-27       Impact factor: 9.594

8.  Therapeutic effects of Holmium-166 chitosan complex in rat brain tumor model.

Authors:  Ryoong Huh; Yong Sook Park; Jong Doo Lee; Young Sun Chung; Yong Gou Park; Sang Sup Chung; Jin Woo Chang
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

9.  MR evaluation of radiation synovectomy of the knee by means of intra-articular injection of holmium-166-chitosan complex in patients with rheumatoid arthritis: results at 4-month follow-up.

Authors:  Sang Hoon Lee; Jin Suck Suh; Ho Seok Kim; Jong Doo Lee; Jungsik Song; Soo Kon Lee
Journal:  Korean J Radiol       Date:  2003 Jul-Sep       Impact factor: 3.500

10.  Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities.

Authors:  Nurul Ab Aziz Hashikin; Chai-Hong Yeong; Basri Johan Jeet Abdullah; Kwan-Hoong Ng; Lip-Yong Chung; Rehir Dahalan; Alan Christopher Perkins
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.